GlassScriptPhysician profile
Martha Davault
NPI 1942810072
$2,213.98
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $579 · 2022: $1,223 · 2023: $390 · 2024: $22.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $662.55 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $511.70 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $218.74 | 2021-2023 | Dupixent |
| Sun Pharmaceutical Industries INC. | $168.53 | 2021-2023 | Ilumya |
| Lilly USA, LLC | $164.69 | 2021-2023 | Olumiant |
| Amgen INC. | $156.76 | 2021-2022 | |
| Genzyme Corporation | $97.68 | 2021-2022 | |
| Janssen Biotech, INC. | $82.05 | 2021-2022 | |
| Organogenesis INC. | $42.08 | 2022 | |
| Janssen Scientific Affairs, LLC | $26.21 | 2022 | |
| Almirall LLC | $20.10 | 2023 | Seysara |
| Arcutis Biotherapeutics, INC. | $19.66 | 2023 | |
| Galderma Laboratories, L.P. | $15.37 | 2022 | |
| Ucb, INC. | $14.01 | 2021 | |
| Leo Pharma INC. | $13.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martha Davault listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.